Implementation of intraperitoneal chemotherapy for the treatment of ovarian cancer.
In January 2006, a clinical announcement made by the National Cancer Institute suggested that intraperitoneal chemotherapy become standard care for patients with newly diagnosed stage III, optimally debulked epithelial ovarian cancer. Intraperitoneal chemotherapy is new to many healthcare providers (i.e., physicians, nurses, and pharmacists). This article will discuss how to implement intraperitoneal chemotherapy in practice. Education and experience are the keys to successful implementation.
Hydzik
Catherine
C
Department of Nursing, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. hydzikc@mskcc.org
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral / Q000009:adverse effects / Q000379:methods / Q000451:nursing*; D007318:Inservice Training; D009519:New York City; D009740:Nursing Staff / Q000193:education*; D010051:Ovarian Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents